TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,846,248 | -66.9% | 579,695 | -1.7% | 0.00% | -66.7% |
| Q2 2023 | $14,646,636 | +107.5% | 589,639 | +25.7% | 0.00% | +50.0% |
| Q1 2023 | $7,057,265 | +20.1% | 469,233 | -5.5% | 0.00% | +100.0% |
| Q4 2022 | $5,874,743 | +120.1% | 496,597 | +10.1% | 0.00% | 0.0% |
| Q3 2022 | $2,669,000 | +57.4% | 450,877 | +13.1% | 0.00% | – |
| Q2 2022 | $1,696,000 | -66.5% | 398,776 | -25.0% | 0.00% | -100.0% |
| Q1 2022 | $5,059,000 | -50.0% | 532,054 | -0.0% | 0.00% | -50.0% |
| Q4 2021 | $10,110,000 | -46.2% | 532,101 | -5.8% | 0.00% | -50.0% |
| Q3 2021 | $18,802,000 | -8.9% | 564,978 | +6.2% | 0.00% | 0.0% |
| Q2 2021 | $20,640,000 | -16.0% | 532,100 | +4.3% | 0.00% | -20.0% |
| Q1 2021 | $24,585,000 | -10.5% | 510,082 | -3.5% | 0.01% | -16.7% |
| Q4 2020 | $27,484,000 | +120.2% | 528,348 | +13.3% | 0.01% | +100.0% |
| Q3 2020 | $12,479,000 | +47.0% | 466,317 | +7.0% | 0.00% | +50.0% |
| Q2 2020 | $8,490,000 | +137.7% | 435,818 | +20.1% | 0.00% | +100.0% |
| Q1 2020 | $3,571,000 | -0.9% | 362,900 | +11.8% | 0.00% | 0.0% |
| Q4 2019 | $3,602,000 | +107.1% | 324,590 | +4.8% | 0.00% | – |
| Q3 2019 | $1,739,000 | -35.4% | 309,689 | -0.4% | 0.00% | -100.0% |
| Q2 2019 | $2,690,000 | +18.9% | 311,004 | +10.5% | 0.00% | 0.0% |
| Q1 2019 | $2,262,000 | +98.2% | 281,377 | +1.1% | 0.00% | – |
| Q4 2018 | $1,141,000 | -29.0% | 278,294 | -3.0% | 0.00% | – |
| Q3 2018 | $1,606,000 | -55.8% | 286,843 | +3.8% | 0.00% | -100.0% |
| Q2 2018 | $3,633,000 | +3.4% | 276,325 | +11.7% | 0.00% | 0.0% |
| Q1 2018 | $3,512,000 | +74.2% | 247,313 | +0.6% | 0.00% | 0.0% |
| Q4 2017 | $2,016,000 | -43.1% | 245,856 | -17.7% | 0.00% | 0.0% |
| Q3 2017 | $3,540,000 | +18.5% | 298,649 | +0.5% | 0.00% | 0.0% |
| Q2 2017 | $2,987,000 | -5.7% | 297,176 | +9.3% | 0.00% | 0.0% |
| Q1 2017 | $3,168,000 | +252.4% | 271,879 | +40.7% | 0.00% | – |
| Q4 2016 | $899,000 | -34.1% | 193,235 | +9.7% | 0.00% | – |
| Q3 2016 | $1,364,000 | +27.5% | 176,168 | -0.3% | 0.00% | – |
| Q2 2016 | $1,070,000 | -22.9% | 176,637 | +8.4% | 0.00% | – |
| Q1 2016 | $1,387,000 | -32.6% | 162,888 | -5.6% | 0.00% | -100.0% |
| Q4 2015 | $2,059,000 | +20.1% | 172,579 | +1.4% | 0.00% | 0.0% |
| Q3 2015 | $1,715,000 | -59.5% | 170,183 | -33.4% | 0.00% | 0.0% |
| Q2 2015 | $4,239,000 | +22.2% | 255,485 | +14.0% | 0.00% | 0.0% |
| Q1 2015 | $3,468,000 | -4.3% | 224,052 | -2.1% | 0.00% | 0.0% |
| Q4 2014 | $3,624,000 | +65.0% | 228,814 | +11.2% | 0.00% | 0.0% |
| Q3 2014 | $2,196,000 | -2.9% | 205,811 | -14.5% | 0.00% | – |
| Q2 2014 | $2,262,000 | +266.6% | 240,806 | +168.9% | 0.00% | – |
| Q1 2014 | $617,000 | +103.6% | 89,564 | +15.5% | 0.00% | – |
| Q4 2013 | $303,000 | -60.0% | 77,551 | -48.5% | 0.00% | – |
| Q3 2013 | $758,000 | +83.1% | 150,616 | +132.5% | 0.00% | – |
| Q2 2013 | $414,000 | – | 64,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |